Different Doses of Belantamab Mafodotin

Phase II Trial for Evaluation of Alternate Doses and Dosing Schedules of Belantamab Mafodotin in Triple-Class Refractory Multiple Myeloma

Arms / Cohorts

Active Comparator:Group I: Low Dose Belantamab Mafodotin

Accepting patients

Experimental:Group II: Low Dose and High Dose Belantamab Mafodotin

Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print this trial to share with your doctor.

(888) 828-2206

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.